![Karen Hübscher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karen Hübscher
Direttore/Membro del Consiglio presso TECAN GROUP AG
Patrimonio netto: 307 309 $ in data 31/05/2024
Profilo
Karen J.
Hübscher is the founder of FibulaMedical AG, a company founded in 2012, where she holds the title of Managing Director.
She currently holds the position of Vice Chairman at Sandoz AG, Vice Chairman at Sandoz Group AG (since 2023), and Non-Executive Director at Tecan Group AG (since 2012).
She is also a Director at IMD Scholarship Foundation, Schweizerische Management Gesellschaft, BBI Group Pty Ltd., and Dispopharm D&P AG.
In her former positions, she served as Chief Executive Officer & Director at Solvias AG, Director-Investor Relations at Novartis AG (from 2000 to 2006), and Member-European Commercial Operations at Novartis Vaccines & Diagnostics Services AG (from 2006 to 2011).
Dr. Hübscher obtained a graduate and doctorate degree from the Swiss Federal Institute of Technology and an MBA from the International Institute for Management Development.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
TECAN GROUP AG
0.01% | 31/12/2022 | 868 ( 0.01% ) | 307 309 $ | 31/05/2024 |
Posizioni attive di Karen Hübscher
Società | Posizione | Inizio |
---|---|---|
TECAN GROUP AG | Direttore/Membro del Consiglio | 01/04/2012 |
RUTILA RESOURCES LTD | Direttore/Membro del Consiglio | - |
SANDOZ GROUP AG | Direttore/Membro del Consiglio | 01/08/2023 |
Dispopharm D&P AG | Direttore/Membro del Consiglio | - |
FibulaMedical AG | Amministratore Delegato | 01/01/2012 |
Schweizerische Management Gesellschaft | Direttore/Membro del Consiglio | - |
IMD Scholarship Foundation | Direttore/Membro del Consiglio | - |
Sandoz AG
![]() Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Karen Hübscher
Società | Posizione | Fine |
---|---|---|
Novartis Vaccines & Diagnostics Services AG | Corporate Officer/Principal | 01/01/2011 |
░░░░░░░░ ░░ | ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | - |
Formazione di Karen Hübscher
International Institute for Management Development | Masters Business Admin |
Swiss Federal Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
NOVARTIS AG | Health Technology |
TECAN GROUP AG | Health Technology |
SANDOZ GROUP AG | Health Technology |
Aziende private | 8 |
---|---|
Dispopharm D&P AG | |
FibulaMedical AG | |
Novartis Vaccines & Diagnostics Services AG | |
Solvias AG
![]() Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Health Technology |
Schweizerische Management Gesellschaft | |
IMD Scholarship Foundation | |
BBI Group Pty Ltd.
![]() BBI Group Pty Ltd. Other Metals/MineralsNon-Energy Minerals BBI Group Ltd. operates as a resource and energy exploration company. Its projects include include Balla Balla and Eucla West Mineral Sands. The company was founded on October 8, 2009 and is headquartered in Sydney, Australia. | Non-Energy Minerals |
Sandoz AG
![]() Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Karen Hübscher